First oncology mAb biosimilar from Pfizer approved by FDA 14-Mar-2019 By Maggie Lynch US FDA approves Pfizer’s Trazimera, a biosimilar to Roche’s blockbuster product, Herceptin, for the treatment of HER2 positive breast cancer.
Daiichi-Merck partnership lines up Keytruda combo therapy 09-Oct-2018 By Maggie Lynch Daiichi Sankyo announced it has entered into a clinical trial collaboration agreement with Merck & Co. to evaluate an investigational lung cancer treatment.